Literature DB >> 11764927

Inhibition by ticlopidine and its derivatives of human liver cytochrome p450. Mechanism-based inactivation of CYP 2C19 by ticlopidine.

N T Ha-Duong1, S Dijols, A C Macherey, P M Dansette, D Mansuy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11764927     DOI： 10.1007/978-1-4615-0667-6_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

1.  Interspecies pharmacokinetics and in vitro metabolism of SQ109.

Authors:  Lee Jia; Patricia E Noker; Lori Coward; Gregory S Gorman; Marina Protopopova; Joseph E Tomaszewski
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.

Authors:  L E Korhonen; M Turpeinen; M Rahnasto; C Wittekindt; A Poso; O Pelkonen; H Raunio; R O Juvonen
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

Review 3.  Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.

Authors:  Siamak Cyrus Khojasteh; Saileta Prabhu; Jane R Kenny; Jason S Halladay; Anthony Y H Lu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-19       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.